Morgan Stanley (MS) 13D/13G Filings for Pharming Group N.V. (PHAR)

Morgan Stanley 13D and 13G filings for Pharming Group N.V.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-04-07
4:04 pm
Sale		 2025-03-31 13G Pharming Group N.V.
PHAR		 MORGAN STANLEY
MS		 8,471,801
1.200%		 -35,689,678decrease
(-80.82%)		 Filing
2024-11-08
3:03 pm
Purchase		 2024-09-30 13G Pharming Group N.V.
PHAR		 MORGAN STANLEY
MS		 44,161,479
6.500%		 44,161,479increase
(New Position)		 Filing